Established · publishing since 1973Rising activity
Adrenal and Paraganglionic TumorsHormonal Regulation and HypertensionCancer, Hypoxia, and MetabolismGlioma Diagnosis and TreatmentGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Publications
297
Citations
18,615
Est. group size
~15
Recurring co-author estimate
Active years
54
Publishing since 1973
In context
Among 4,953 established Medicine PIs within our index
Citations: 18,615p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 20.0p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~3 · 62% small-team papers (≤3 authors) · across 17 venues
Publication cadence
Publications per year over the last 10 years — averaging 20.0/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
Frontiers in Endocrinology · 2023
- Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease
Frontiers in Endocrinology · 2023
- Targeting of a New Node in Lipid Metabolism as a Potential Treatment Strategy for ACC
Endocrinology · 2023
- Supplementary Figure 3 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure 1 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure Legend from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Tables 1 and 2 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Data from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Data from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure 2 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure 2 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Tables 1 and 2 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure Legend from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure 1 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
- Supplementary Figure 3 from Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
2023
Publishes in
- Journal of the Endocrine Society×23
- Cancer Research×5
- Endocrine Abstracts×5
- Endocrinology×4
- Molecular and Cellular Endocrinology×4
Similar researchers
By research-topic overlap
- Dipika R. Mohan
Medicine · University of Michigan
- Antônio Marcondes Lerário
Medicine · University of Michigan
- Tobias Else
Medicine · University of Michigan
- Thomas J. Giordano
Medicine · University of Michigan
- Lívia M. Mermejo
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile